4.5 Article

Personalized care of patients with heart failure: are we ready for a REWOLUTION? Insights from two international surveys on healthcare professionals' needs and patients' perceptions

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

Theresa A. McDonagh et al.

Summary: All experts involved in the development of the guidelines have declared their interests, and the declarations have been compiled and published in a supplementary report. The report can be accessed on the ESC website. The supplementary data provide background information and detailed discussion of the data that form the basis for the guidelines.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction

Jasper Tromp et al.

Summary: This study assessed the prescription rates and doses of medications for HFrEF patients in 44 countries and found that patients in low- and middle-income countries were less likely to receive guideline-recommended treatment. Additionally, it was found that using target doses of RAS inhibitors and beta-blockers, as recommended by guidelines, was associated with better 1-year survival.

EUROPEAN HEART JOURNAL (2022)

Article Medicine, General & Internal

Network meta-analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction

Vincenzo De Marzo et al.

Summary: Combination medical therapy including neurohormonal inhibitors and newer drugs, especially ARNI and SGLT2i, confers the maximum benefit with regard to HFrEF prognosis.

JOURNAL OF INTERNAL MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

Optimizing Foundational Therapies in Patients With HFrEF How Do We Translate These Findings Into Clinical Care?

Abhinav Sharma et al.

Summary: Patients with heart failure and reduced ejection fraction (HFrEF) have a high risk of adverse outcomes. It is crucial to initiate and titrate guideline-directed medical therapy (GDMT) to reduce morbidity and mortality. Clinical practice guidelines emphasize the need for early initiation of therapies that have cardiovascular benefit. However, many barriers exist in the initiation and optimization of GDMT.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2022)

Article Cardiac & Cardiovascular Systems

Use of Guideline-Directed Medical Therapy in Patients Aged = 65 Years After the Diagnosis of Heart Failure: A Canadian Population-Based Study

Muizz Wahid et al.

Summary: Current pharmacologic management for HFrEF patients does not align with Canadian guidelines. Innovative strategies are needed to optimize care for HFrEF patients.

CJC OPEN (2022)

Article Cardiac & Cardiovascular Systems

Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology

Tiny Jaarsma et al.

Summary: Self-care is crucial in the long-term management of chronic heart failure, with the potential to improve quality of life and reduce mortality and readmission rates for patients. While guidelines offer general advice, healthcare professionals working with heart failure patients require more specific recommendations to effectively support their self-care practices.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry

Martin R. Cowie et al.

Summary: The international QUALIFY Registry suggests that few patients with HFrEF achieve target doses of disease-modifying medication, especially older patients and those with co-morbidity. Urgent quality improvement initiatives are required.

ESC HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction

Michael McDonald et al.

Summary: This article provides comprehensive recommendations and practical tips for pharmacologic management of patients with heart failure with reduced ejection fraction (HFrEF), focusing on novel pharmacologic therapies. A new standard of pharmacologic care for HFrEF is defined, emphasizing the integration of prioritized pharmacologic with nonpharmacologic and invasive therapies after diagnosis.

CANADIAN JOURNAL OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology

Giuseppe M. C. Rosano et al.

Summary: Implementation of treatment in heart failure is hindered by poor tolerability and renal function issues, leading to difficulty in reaching target drug doses. A personalized approach to therapy based on patient profiles may be more effective than traditional forced titration of each drug class.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Care Gaps in Adherence to Heart Failure Guidelines Clinical Inertia or Physiological Limitations?

Marilyne Jarjour et al.

JACC-HEART FAILURE (2020)

Article Cardiac & Cardiovascular Systems

Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction

Stephen J. Greene et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Medical Therapy for Heart Failure With Reduced Ejection Fraction

Stephen J. Greene et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Public, Environmental & Occupational Health

Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study

Tiew-Hwa K. Teng et al.

LANCET GLOBAL HEALTH (2018)

Article Cardiac & Cardiovascular Systems

The Optimize Heart Failure Care Program: Initial lessons from global implementation

Martin R. Cowie et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)